Lojanapiwat 2008.
Methods |
|
|
Participants |
|
|
Interventions | Treatment group 1
Treatment group 2
Control group
If participants developed renal colic during treatment, they were given an IM injection of 75 mg diclofenac in the emergency department. |
|
Outcomes |
|
|
Funding sources | Astellas Pharma (Thailand). | |
Declarations of interest | None. | |
Notes | Sample size calculated. | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: "Block randomized in three groups by the assistant nurse." Comment: This method of random sequence generation was considered to have unclear risk of bias. |
Allocation concealment (selection bias) | Unclear risk | No quotes available. Insufficient information to permit judgement. Comment: Owing to insufficient information, allocation concealment was considered to have unclear risk of bias. |
Blinding of participants and personnel (performance bias) All outcomes | High risk | No quote available. Comment: no blinding; therefore risk of performance bias was considered to be high. |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | No quotes available. No blinding of outcome assessments described. Comment: Owing to insufficient information, risk of detection bias was considered to be unclear. |
Incomplete outcome data (attrition bias) All outcomes | Low risk | No quotes available. Comment: No participants lost to follow‐up; therefore risk of attrition bias was considered to be low. |
Selective reporting (reporting bias) | Low risk | No quotes available. Expected outcomes were reported according to objectives. Comment: Risk of reporting bias was therefore considered to be low. |
Other bias | Low risk | No quotes available. Study appears to be free of other sources of bias. Comment: No other sources of bias could be found; therefore risk of other bias was considered to be low. |